We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Comments on "Real‐world re‐treatment outcomes of direct‐acting antiviral therapy failure in patients with chronic hepatitis C".
- Authors
Nicolini, Laura A.; Menzaghi, Barbara; Molteni, Chiara; Vichi, Francesca; Cascio, Antonio; Parisini, Andrea; De Socio, Giuseppe V.; Falasca, Katia; Bonfanti, Paolo; Di Biagio, Antonio
- Abstract
Comments on "Real-world re-treatment outcomes of direct-acting antiviral therapy failure in patients with chronic hepatitis C" Keywords: Anti-hepatitis C virus DAA (directly acting antivirals); Antiviral agents; Hepatitis C virus; Hepatitis virus; Virus classification EN Anti-hepatitis C virus DAA (directly acting antivirals) Antiviral agents Hepatitis C virus Hepatitis virus Virus classification 436 438 3 12/13/21 20220201 NES 220201 Elhence et al.1 assessed the retreatment outcomes of direct-acting antivirals (DAAs) therapy failure in a cohort of 40 patients with chronic hepatitis C (HCV) and previous virological failure (VF) to DAAs. Addressing hesitancy in HCV retreatment prescription and nonadherence to second-line DAAs with a tailored approach is crucial to scale up HCV treatment and eradicate HCV infection in people with previous VF to DAAs.
- Subjects
CHRONIC hepatitis C; HEPATITIS C; CHRONIC hepatitis B; DIRECTLY observed therapy
- Publication
Journal of Medical Virology, 2022, Vol 94, Issue 2, p436
- ISSN
0146-6615
- Publication type
Article
- DOI
10.1002/jmv.27329